Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work

Official title: Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes: The D1ANA Study

Run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · NCT07667504 · Data updated 2026-11-12

We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.

More Obesity & Overweight trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment75 (estimated)
SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Academic / other
Locations1 site (Málaga, Málaga)
StatusRecruiting
StartedJuly 2, 2026
Main results expectedJuly 2028
Study endsJuly 2028
Registry record updatedJuly 15, 2026
Trial IDNCT07667504 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Type 1 diabetes, overweight or obese (BMI 25–45 kg/m2), on intensive insulin therapy, CGM user, and stable treatment plan.

Probably not a fit

Patients who do not respond to dietary interventions or who experience adverse glycemic events or safety concerns may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares three weight-management approaches in adults with T1D and overweight/obesity: moderate carbohydrate restriction, early time-restricted eating, and standard calorie restriction. Participants will have T1D managed with intensive insulin therapy, use CGM, and meet HbA1c and BMI criteria. The trial aims to determine which approach yields meaningful weight loss while maintaining glycemic control and safety. Outcomes likely include changes in weight, metabolic markers, and insulin requirements. The study is conducted at a single site in Málaga, Spain, led by a regional health research foundation.

Why it matters

Potential benefit: If successful, the trial could identify practical dietary options to achieve weight loss and improve health in adults with T1D and overweight/obesity.

How similar studies have gone: Previous work in Type 2 diabetes and obesity supports weight-loss strategies, but evidence in T1D is limited and this study explores novel approaches in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* T1D treated with intensive insulin therapy (multiple daily insulin injections or continuous subcutaneous insulin infusion systems)
* HbA1c 6.5-9%
* BMI ≥ 25 and ≤ 45 kg/m2
* Active prescription and use of CGM
* Active prescription for glucagon

Exclusion Criteria:

* Pregnancy, pregnancy planning, or breastfeeding
* Forms of diabetes other than T1D, or T1D duration \< 1 year
* Previous cardiovascular events (acute myocardial infarction or stroke), heart failure, unstable coronary artery disease, chronic kidney disease with estimated glomerular filtration rate ≤ 30 mL/min/m², cirrhosis, or presence of active cancer
* Unstable diabetes, episodes of glycemic decompensation (diabetic ketoacidosis) or severe hypoglycemia (level 3) within the past year.
* Planned change in treatment during the study (switching from multiple daily insulin injections to continuous insulin infusion, or vice versa)
* Use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, GLP-1/GIP agonists, or other medications that may influence weight loss
* Having experienced a change in body weight greater than 5% within the 3 months before screening
* Following any form of diet prior to inclusion, carbohydrate restriction, or intermittent fasting
* History of eating disorders or alcohol abuse
* Inability to follow the dietary recommendations
* Presence of other conditions that, in the investigator's judgment, may compromise participation in the study.

Where it's running

  • Virgen de la Victoria University Hospital
    Málaga, Málaga, Spain
    Recruiting

Study contacts

  • Principal investigator: José Ignacio Martínez-Montoro, MD, PhD — Virgen de la Victoria University Hospital, Málaga, Spain
  • Study coordinator: José Ignacio Martínez-Montoro, MD, PhD
  • Email: martinezmontoro@ibima.eu
  • Phone: +34 951032647

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.